Canaccord raises Helen of Troy stock price target on sales recovery
Canaccord raised Helen of Troy's (HELE) price target to $26.00, citing sales recovery and expected growth in home & outdoor and Beauty & Wellness segments. The stock trades at $25.64, below InvestingPro’s Fair Value estimate. The firm anticipates gross margin improvements and higher SG&A expenses due to investments. HELE reported Q1 fiscal 2027 earnings of $0.17 per share, beating expectations, and raised its full-year revenue outlook.
How this was made
The 30-second read
Why it matters
Analyst optimism may prompt short‑term buying, but underlying operational risks remain.
Market read
Provides a modest catalyst for HELE but limited broader market relevance.
What to watch
Potential slowdown in discretionary spending could dampen future growth.
Background
The article recaps Q1 fiscal 2027 results and reports an analyst price‑target raise.
Ticker impact
Canaccord raised its price target on Helen of Troy to $26, citing sales recovery in Home & Outdoor and Beauty & Wellness.
likely upward pressure as the market prices in the higher target
Target raise reflects improved sales outlook, but the company still faces margin and supply‑chain concerns.
Market effects
May lift sentiment for consumer‑goods and specialty‑products peers.
Limited to US small‑cap consumer segment.
Minimal global impact.
Counterpoint
Margin pressure and tariff costs could outweigh sales recovery, keeping the stock flat.
Key entities
- CompanyHelen of Troy
Consumer products maker (NASDAQ:HELE).
- AnalystCanaccord
Equity research firm raising price target.

